{"filing":{"accession_number":"0001104659-26-092973","cik":"0000075252","ticker":"ACH","company_name":"ACCENDRA HEALTH INC/VA/","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"tm2622667d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/75252/000110465926092973/tm2622667d1_8k.htm"},"events":[{"id":26308,"run_id":23901,"accession_number":"0001104659-26-092973","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Edward A. Pesicka, President, Chief Executive Officer, and Director of Accendra Health, has announced his intention to retire and step down from both his executive role and the Board by the end of 2026 or upon appointment of a successor. The Board has commenced a succession process to identify a replacement.","company_name":"ACCENDRA HEALTH INC/VA/","ticker":"ACH","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":[{"id":27387,"accession_number":"0001104659-26-092973","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Edward A. Pesicka, the President, Chief Executive Officer, and Director of Accendra Health, has announced his intention to retire and step down from the Board by the end of 2026 or upon appointment of a successor. This is a departure of a named executive officer and director. While the filing notes the Board has commenced a succession process, the principal disclosed action is Pesicka's departure, not an appointment of a replacement. The departure of a CEO is material to investors assessing the company's leadership continuity and future direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T10:37:42.914863+00:00","company_name":"","ticker":null,"filing_date":""},{"id":27388,"accession_number":"0001104659-26-092973","item_number":"7.01","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that President and Chief Executive Officer Edward A. Pesicka has informed the Board of his plan to retire by the end of 2026 after more than seven years with the Company, and will also retire from the Board. This is a departure of a named executive officer from a principal leadership role. While the press release mentions the Board's successor search process, the principal disclosed action is Pesicka's retirement/departure, making this an exec_departure event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T10:37:42.914863+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27387,"accession_number":"0001104659-26-092973","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Edward A. Pesicka, the President, Chief Executive Officer, and Director of Accendra Health, has announced his intention to retire and step down from the Board by the end of 2026 or upon appointment of a successor. This is a departure of a named executive officer and director. While the filing notes the Board has commenced a succession process, the principal disclosed action is Pesicka's departure, not an appointment of a replacement. The departure of a CEO is material to investors assessing the company's leadership continuity and future direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T10:37:42.914863+00:00","company_name":"ACCENDRA HEALTH INC/VA/","ticker":"ACH","filing_date":"2026-08-10"},{"id":27388,"accession_number":"0001104659-26-092973","item_number":"7.01","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The filing discloses that President and Chief Executive Officer Edward A. Pesicka has informed the Board of his plan to retire by the end of 2026 after more than seven years with the Company, and will also retire from the Board. This is a departure of a named executive officer from a principal leadership role. While the press release mentions the Board's successor search process, the principal disclosed action is Pesicka's retirement/departure, making this an exec_departure event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T10:37:42.914863+00:00","company_name":"ACCENDRA HEALTH INC/VA/","ticker":"ACH","filing_date":"2026-08-10"}]}